Iceland vs Small island developing states (SIDS): Proportion of the target population who received
Iceland
98.0%
in 2024
Small island developing states (SIDS)
63.0%
in 2024
Iceland rank
14th
Small island developing states (SIDS) rank
16th
Proportion of the target population who received over time
- Iceland
- Small island developing states (SIDS)
How they compare
Iceland currently reports 98.0% against 63.0% in Small island developing states (SIDS), a difference of 35.0%.
That makes Iceland's figure about 1.6 times Small island developing states (SIDS)'s.
The two have swapped places 2 times across 22 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | Small island developing states (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 23.3% | 69.0% | Iceland |
| 2010s | 93.9% | 31.6% | 62.3% | Iceland |
| 2020s | 74.0% | 56.8% | 17.2% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Iceland or Small island developing states (SIDS)?
- Iceland, at 98.0% against 63.0% in Small island developing states (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between Iceland and Small island developing states (SIDS)?
- 35.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Small island developing states (SIDS)?
- 22 years are reported by both, from 2003 to 2024.
- How do Iceland and Small island developing states (SIDS) rank globally for proportion of the target population who received?
- Iceland ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.